VICORE PHARMA HOLDING AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.68 SEK | -2.91% |
|
+3.73% | +17.63% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Vicore Pharma Holding AB is a Sweden-based drug-development company. The Company's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The Company is a wholly owned subsidiary of Mintage Scientific AB.
Calendar
2024-05-02
- Q1 2024 Earnings Release
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
17.18
SEK
Average target price
61.5
SEK
Spread / Average Target
+257.97%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.63% | 176M | |
| -2.00% | 104B | |
| +2.04% | 97.42B | |
| +0.79% | 22.2B | |
| -17.73% | 21.23B | |
| -11.11% | 18.33B | |
| -42.83% | 16.35B | |
| -15.82% | 15.06B | |
| +3.74% | 13.98B | |
| +34.76% | 11.66B |
- Stock Market
- Equities
- VICO Stock
- News Vicore Pharma Holding AB
- Vicore Pharma : Starts Phase 3 Trial for COVID-19 Treatment, Shares Rise
